AHFS Drug Information 2023 Doody's Expert Review Review Questionnaire ISBN: 9781585287062 ISBN-10: 1585287067 Copyright: 2023 Edition: 1st Author: ASHP, Doody's Expert Review    Score: 97 Doody's Star Rating™ and Doody's Expert Review provide by Doody Enterprises, Inc. Reviewer: Yen Dang,  PharmD  (University of Maryland Eastern Shore) Description This book covers comprehensive information on the safety and efficacy of drugs. AHFS DI is the longest published, federally designated drug compendium in the United States issued by a scientific and professional society. The book is written by pharmacists and reviewed by over 500 experts to contain the most up-to-date, evidence-based drug information with therapeutic guidelines and off-label uses. This edition was published in 2023. Purpose The mission of this book is to provide an evidence-based foundation for safe and effective drug therapy. The book meets its objective as it has a long-standing history of rigorous science-based editorial processes supported by more than 97,000 references. The information provided is objective and free from the influence of pharmaceutical companies as the editorial decisions are evidence-based and made independent of these third parties. Audience The book is written for pharmacists and other healthcare providers to access specific guidance needed to prescribe and monitor drug therapy safely and effectively. It includes over 97,000 cited references linked to 735,000 statements with 70,000 supporting evidence sources. Using an independent, evidence-based evaluative process, the drug monographs incorporate information from pertinent references in the literature and expert therapeutic guidelines. This point-by-point analysis and evaluation of the literature makes this reference comprehensive, evaluative, and unbiased. Features The drug monographs are arranged by the AHFS Pharmacologic-Therapeutic Classification to provide readers with an easy review of information on a group of drugs with similar activity. Within each subclass, the monographs are arranged alphabetically by generic name. The monographs contain an introductory description, risk evaluation and mitigation strategies (REMS), dosage and administration, cautions, acute and chronic toxicity, drug interactions, laboratory test inferences, pharmacology, mechanism of action, spectrum, resistance, pharmacokinetics, chemistry and stability, preparations, and references. Both labeled and off-labeled drug uses are included. Each monograph is organized such that the most clinically relevant and frequently sought information appears at the beginning. Assessment This book is a valuable reference to access drug information, from current therapeutic guidelines to off-label uses. The updates in the 2023 reference contain the latest information about COVID-19 vaccines and therapeutics, contemporary treatment topics, Standardize 4 Safety concentration standards for IV and oral liquid drugs, breakthrough oncology drugs approved through the FDA's accelerated approval program, and pharmacogenomic considerations. The updates also contain clinical perspective sections that include place of therapy discussions and recommendations from therapeutic guidelines. Review Questionnaire Range Question Score 1-10 Are the author's objectives met? 10 1-10 Rate the worthiness of those objectives. 10 1-5 Is this written at an appropriate level? 5 1-5 Is there significant duplication? (1=significant, 5=insignificant) 4 1-5 Are there significant omissions? (1=significant, 5=insignificant) 5 1-5 Rate the authority of the authors. 5 1-5 Are there sufficient illustrations? N/A 1-5 Rate the pedagogic value of the illustrations. N/A 1-5 Rate the print quality of the illustrations. N/A 1-5 Are there sufficient references? N/A 1-5 Rate the currency of the references. N/A 1-5 Rate the pertinence of the references. N/A 1-5 Rate the helpfulness of the index. 4 1-5 If important in this specialty, rate the physical appearance of the book N/A 1-10 Is this a worthwhile contribution to the field? 10 1-10 If this is a 2nd or later edition, is this new edition needed? 10 ©2024 Doody Enterprises, Inc.